Study of Blood Samples in Patients With Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00959556|
Recruitment Status : Unknown
Verified August 2009 by National Cancer Institute (NCI).
Recruitment status was: Recruiting
First Posted : August 14, 2009
Last Update Posted : January 10, 2011
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy.
PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Other: laboratory biomarker analysis|
- Identify constitutional gene variants associated with a change in response.
OUTLINE: Blood samples are collected periodically for analysis of genetic factors.
|Study Type :||Observational|
|Estimated Enrollment :||900 participants|
|Official Title:||Search for Genetic Factors Predictive of Response to Chemotherapy in Patients With or Who Has a Mammary Adenocarcinoma in Neo-adjuvant or Metastatic Setting|
|Study Start Date :||November 2007|
|Estimated Primary Completion Date :||December 2011|
- Histologic complete response (Chevallier and Sataloff) or tumor response (RECIST)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00959556
|Centre Oscar Lambret||Recruiting|
|Lille, France, 59020|
|Contact: Jacques Bonneterre, MD, PhD 33-3-20-29-5959 firstname.lastname@example.org|
|Principal Investigator:||Jacques Bonneterre, MD, PhD||Centre Oscar Lambret|